
A high-title (2000 UCD) adrenal cortex extract was used in the support management of 30 neoplastic patients. Evaluation was based on performance status (PS) according to Karnofsky and symptom incidence before and after the treatment. PS improved in 30%. There was a marked reduction in asthenia and anorexia, with significant changes in headache, nausea, and vomiting. Blood pressure, heart rate, and the blood chemistry picture were not altered.
Adult, Male, Clinical Trials as Topic, Time Factors, Middle Aged, Drug Combinations, Adrenal Cortex Hormones, Pregnenediones, Neoplasms, Injections, Intravenous, Humans, Female, Aged
Adult, Male, Clinical Trials as Topic, Time Factors, Middle Aged, Drug Combinations, Adrenal Cortex Hormones, Pregnenediones, Neoplasms, Injections, Intravenous, Humans, Female, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
